FOXO Technologies Company Description
FOXO Technologies Inc. develops epigenetic biomarkers technology solutions in the United States.
The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness, and aging.
It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers.
FOXO Technologies Inc. was founded in 2020 and is based in Minneapolis, Minnesota.
| Country | United States |
| Founded | 2020 |
| Industry | Computer Programming, Data Processing, And Other Computer Related Services |
| Sector | Healthcare |
| Employees | 135 |
| CEO | Seamus Lagan |
Contact Details
Address: 729 North Washington Avenue Minneapolis, Delaware 55401 United States | |
| Phone | 612 562 9447 |
| Website | foxotechnologies.com |
Stock Details
| Ticker Symbol | FOXOW |
| Exchange | OTCMKTS |
| Stock Type | Warrants |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 7370 |
Key Executives
| Name | Position |
|---|---|
| Seamus Lagan | Chief Executive Officer |
| Martin Ward | Chief Financial Officer |